TOP1 and cancer: To determine whether TOP1-induced mutations resulting in the ID4 signature can be detected in vivo, we next studied an RER-deficient mouse cancer model in which Villin-cre conditional deletion of Rnaseh2b and Tp53 results in intestinal malignancy29.